In these cells, changes in the Kv11.1 current activity relate to alteration of a variety of hallmarks of cancer, ranging from proliferation to metastasis; therefore, this channel could be considered as a potential target for cancer therapeutics [6,7,8,9]. This evidence concerns the gene KCNH2 and cancer.